How does vascepa interact with blood thinners?

According to the prescribing information for Vascepa (icosapent ethyl), an omega-3 fatty acid medication used to lower triglyceride levels, there is a potential interaction with blood thinners [1].

Vascepa should be used with caution in patients taking anticoagulant or antiplatelet medications, such as warfarin, aspirin, or nonsteroidal anti-inflammatory drugs (NSAIDs), as concomitant use may increase the risk of bleeding [1].

Clinical trials have shown that Vascepa does not affect warfarin’s anticoagulant effects when given together, but its administration does result in a significant increase in international normalized ratio (INR) values in patients taking warfarin [2].

Additionally, case reports and clinical trials suggest that concomitant use of Vascepa and anticoagulant medications may result in increased bleeding risk [3].

The exact mechanism of this interaction is not well understood, but it’s possible that the omega-3 fatty acids in Vascepa may inhibit platelet aggregation or affect the synthesis or activity of clotting factors [4].

Healthcare providers should carefully monitor patients taking both Vascepa and blood thinners, as well as patients with a history of bleeding disorders or those at risk for significant bleeding [1].

Sources:

[1] https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5c1fba2d-8d5e-43c4-87bf-5a2e3e2fe4b7
[2] https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5c1fba2d-8d5e-43c4-87bf-5a2e3e2fe4b7 (PDF pg. 17-18)
[3] [ DrugPatentWatch.com (https://www.drugpatentwatch.com/drug/icosapent-ethyl)]

Note: Consult a qualified healthcare professional for personalized guidance on interacting medications.